Kerrou K - Search Results

1

Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections.

Ohnona J, Durand P, Amegnizin JL, Kerrou K. Ohnona J, et al. Among authors: kerrou k. Clin Nucl Med. 2016 Jun;41(6):492-3. doi: 10.1097/RLU.0000000000001206. Clin Nucl Med. 2016. PMID: 26975013

2

Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results.

Jacob T, Grahek D, Younsi N, Kerrou K, Aide N, Montravers F, Balogova S, Colombet C, De Beco V, Talbot JN. Jacob T, et al. Among authors: kerrou k. Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1266-9. doi: 10.1007/s00259-003-1249-3. Epub 2003 Jul 10. Eur J Nucl Med Mol Imaging. 2003. PMID: 12856157 Clinical Trial.

3

[18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management.

Grahek D, Montravers F, Kerrou K, Aide N, Lotz JP, Talbot JN. Grahek D, et al. Among authors: kerrou k. Eur J Nucl Med Mol Imaging. 2004 Feb;31(2):179-88. doi: 10.1007/s00259-003-1348-1. Eur J Nucl Med Mol Imaging. 2004. PMID: 15129699 Clinical Trial.

4

Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET.

Montravers F, Grahek D, Kerrou K, Younsi N, Petegnief Y, de Beco V, Colombet-Lamau C, Talbot JN. Montravers F, et al. Among authors: kerrou k. Nucl Med Commun. 2004 Feb;25(2):105-13. doi: 10.1097/00006231-200402000-00003. Nucl Med Commun. 2004. PMID: 15154697 Clinical Trial.

5

PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT.

Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, Grahek D, Montravers F, Poupon R, Rosmorduc O. Talbot JN, et al. Among authors: kerrou k. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1285-9. doi: 10.1007/s00259-006-0164-9. Epub 2006 Jun 27. Eur J Nucl Med Mol Imaging. 2006. PMID: 16802155

6

Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?

Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, Gutman F, Grangé JD, Lotz JP, Talbot JN. Montravers F, et al. Among authors: kerrou k. J Nucl Med. 2006 Sep;47(9):1455-62. J Nucl Med. 2006. PMID: 16954553 Free article.

7

[FDG PET and its impact on patient's management in oncology].

Talbot JN, Montravers F, Grahek D, Kerrou K, Gutman F, Cailleux N. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1339-46. doi: 10.1016/s0755-4982(06)74817-5. Presse Med. 2006. PMID: 16969330 Review. French.

8

[PET and malignant cerebral tumors].

Talbot JN, Kerrou K, Gault N, Gutman F, Grahek D, Touboul E, Schlienger M, Montravers F. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1347-53. doi: 10.1016/s0755-4982(06)74818-7. Presse Med. 2006. PMID: 16969331 Review. French.

9

[PET in head and neck cancers].

Talbot JN, Périé S, Kerrou K, Montravers F, Balogova S, Grahek D, Gutman F, Saint Guily JL. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1355-69. doi: 10.1016/s0755-4982(06)74819-9. Presse Med. 2006. PMID: 16969332 Review. French.

10

[FDG-PET in localization of cancers of unknown primary origin].

Talbot JN, Kerrou K, Gutman F, Périé S, Grahek D, Roulet E, Saint Guily JL, Montravers F. Talbot JN, et al. Among authors: kerrou k. Presse Med. 2006 Sep;35(9 Pt 2):1371-6. doi: 10.1016/s0755-4982(06)74820-5. Presse Med. 2006. PMID: 16969333 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters